GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


COMPOSITE OUTCOMES IN CLINICAL TRIALS


OBJECTIVES

Using composite endpoints permits to decrease sample size needs, to better assess the net effect of an intervention and to minimize bias in presence of competing risks.

This course intends to give you knowledge and expertise on the risk of misinterpretation related to the magnitude of treatment effect.

Sample size, Intervention, Competing risk, Misinterpretation

 

LEARNING OUTCOMES

At the end of this course, you will be able to understand and iscuss the main advantages and limitations of using combined outcomes in clinical trials and how to make a rationale interpretation of this kind of variables.

 

120 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona


avatar

Dr. Xavier Vidal

Universitat Autònoma de Barcelona

avatar

Dr. Montse Bosche

Universitat Autònoma de Barcelona




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners